Search published articles


Showing 2 results for Mohamadi

Mohammad Ali Amirzargar , Masoud Jafari , Behrooz Mohamadi , Abbas Moradi ,
Volume 1, Issue 1 (Journal of Research in Urology, Winter 2016)
Abstract

Introduction: Urinary incontinence is any urine leakage without control from bladder that is classified into persistent incontinence, urge incontinence, overflow incontinence and stress incontinence. Stress incontinence is more prevalent than another types of incontinence and results in economy expenses and social costs. . In this study, we compared the transurethral platelet rich plasma combined with autologous fat injection versus autologous fat injection on abdominal leak point pressure in patients with stress urinary incontinence in Hamadan’s Beheshti Hospital.

Materials and Methods: In this clinical trial study, we studied female patients with stress urinary incontinence in Hamadan’s Beheshti hospital from September 2012 to March 2012. Platelet rich plasma combined with autologous fat were injected into the patient’s bladder neck as a bulking agent. Data were analyzed using SPSS 16. At the end, all analyses were compared at 95 percent level of confidence. Paired t-test statistical analysis was used. Significant level was considered less than 0.05.

Results: The interior – posterior thickness of injected fat tissue along with PRP in MRI and also the level of ALPP increased significantly and the symptoms in patients improved based on questionnaires data.

Conclusions: With regard to different aspects of our study such as the intensity of urinary incontinence in accordance with the questionnaire, changes of thickness in fat tissue using MRI in Sagittal sections, changes in ALPP using Urodynamic and complications resulting from the treatment, the obtained results were promising and its seems that this is one of the treatment options recommended to the patients. Its seems that PRP+FAT may be used as factors to treat females with stress urinary incontinence.


Mehdi Salehipour, Fariba Malekmohamadi, Hossein Amirzargar,
Volume 3, Issue 1 (Spring-Summer 2019)
Abstract

Background & Objective: Prostate cancer is considered to be the most prevalent malignancy among males. Prostate specific antigen (PSA) is used for screening this malignancy. Serum levels of PSA is influenced by liver function. This study evaluated variations of serum levels of PSA amongst cirrhotic patients, before and after receiving liver transplantation.
Methods: All cirrhotic males older than 45 y/o in the waiting list of liver transplant, were enrolled in the study. After receiving a medical history and checking a total PSA (tPSA), patients who had abnormality were excluded from the study. So, 60 patients who underwent liver transplantation surgery, with a normal 3 month follow up liver function tests (LFT) participated in this study. Thereafter the tPSA level was checked again. Ultimately 30 patients performed the tPSA after a successful liver transplant.
Results: The mean age of these 30 patient was 57, and average tPSA before liver transplant was 0.4 ng/dl (range: 0.07-1.6), and was 1.6 (range: 0.2-7.3) after transplant. Wilcoxon test revealed significant differences between pre and post-transplant PSA levels (P˂0.001, Z= -4.68).
Conclusions: Serum levels of PSA, rises after a successful liver transplant. In cirrhotic patients, PSA levels may not be authentic. In this study, PSA levels rose by 1.2 ng/dl post-transplant. This study revealed that tPSA may be neither reliable nor sensitive enough as a routine screening test for cirrhotic patients; and seems to do the screening there is a need for lower levels comparing to healthy people for the test.


Page 1 from 1     

© 2025 CC BY-NC 4.0 | Journal of Research in Urology

Designed & Developed by : Yektaweb